- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02313363
Patient-Centered Smartphone-Based Diabetes Care
December 9, 2014 updated by: Seoul National University Hospital
Feasibility of a Patient-Centered Smartphone-Based Diabetes Care System: a Pilot Study
The investigators developed a patient-centered smartphone-based diabetes care system (PSDCS).
This study was aimed to test the feasibility of the PSDCS.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- type 2 diabetes
- HbA1c levels ≥ 6.5%
Exclusion Criteria:
- severe diabetic complication including severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy, chronic kidney disease stage 4-5, severe diabetic neuropathy, history of diabetic foot, history of angina pectoris, myocardial infarction, and cerebrovascular disease, and peripheral arterial disease
- type 1 diabetes
- insulin therapy other than insulin glargine
- subjects with insulin pump
- history of drug addiction
- history of psychotic disorder
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PSDCS
using the patient-centered smartphone-based diabetes care system (PSDCS) for 12 weeks
|
patient-centered smartphone-based diabetes care system (PSDCS) is composed of 4 modules such as glucose module, diet module, physical activity module, and SNS module.
Participants were instructed to use the PSDCS and to measure blood glucose levels with a Bluetooth glucometer, input daily food intake, and wear an activity tracker.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change of HbA1c
Time Frame: baseline and the end of 12 week
|
baseline and the end of 12 week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change of fasting plasma glucose
Time Frame: baseline and after 12 weeks (within 3 days)
|
baseline and after 12 weeks (within 3 days)
|
change of lipid profile
Time Frame: baseline and after 12 weeks (within 3 days)
|
baseline and after 12 weeks (within 3 days)
|
change of body weight
Time Frame: baseline and after 12 weeks (within 3 days)
|
baseline and after 12 weeks (within 3 days)
|
change of the scores of Summary of Diabetes Self-Care Activities (SDSCA)
Time Frame: baseline and after 12 weeks (within 3 days)
|
baseline and after 12 weeks (within 3 days)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of events of serious hyperglycemia
Time Frame: 12 weeks
|
320 mg/dL or higher by the glucometer readouts
|
12 weeks
|
number of events of hypoglycemia
Time Frame: 12 weeks
|
less than 70 mg/dL by the glucometer readouts
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
December 8, 2014
First Submitted That Met QC Criteria
December 9, 2014
First Posted (Estimate)
December 10, 2014
Study Record Updates
Last Update Posted (Estimate)
December 10, 2014
Last Update Submitted That Met QC Criteria
December 9, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-1301-075-459
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on patient-centered smartphone-based diabetes care system
-
Cook County HealthAgency for Healthcare Research and Quality (AHRQ)CompletedMultiple Co-morbiditiesUnited States
-
King Abdullah International Medical Research CenterHarvard UniversityCompleted
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins Community...CompletedHypertensionUnited States
-
University Hospital, BordeauxCompletedPatient Centred CareFrance
-
University of PittsburghCompletedEnd-stage Renal Disease
-
University of Wisconsin, MadisonCompleted
-
Ohio State UniversityCompletedChronic Disease | Communication Research | Advance Care PlanningUnited States
-
National Committee for Quality AssuranceAmerican Society of Clinical Oncology; RAND; Independence Blue Cross; National... and other collaboratorsCompleted
-
Istanbul Bilgi UniversityIstanbul University - Cerrahpasa (IUC)Enrolling by invitationPressure Injury | Incontinence-associated DermatitisTurkey
-
University of PittsburghPatient-Centered Outcomes Research Institute; Dartmouth CollegeCompletedSchizophrenia | Bipolar Disorder | Major DepressionUnited States